E,E-RAMB4

CAS No. 919091-61-5

E,E-RAMB4( —— )

Catalog No. M33081 CAS No. 919091-61-5

PTP1B-IN-8 is a potent and selective inhibitor of protein tyrosine phosphatase-1B (PTP1B).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 187 In Stock
10MG 283 In Stock
25MG 452 In Stock
50MG 631 In Stock
100MG 848 In Stock
200MG 1107 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    E,E-RAMB4
  • Note
    Research use only, not for human use.
  • Brief Description
    PTP1B-IN-8 is a potent and selective inhibitor of protein tyrosine phosphatase-1B (PTP1B).
  • Description
    (E,E)-RAMB4 is a potent and selective potent protein tyrosine phosphatase-1B (PTP1B) inhibitor extracted from patent CN103626692A, example 1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Phosphatase
  • Recptor
    Phosphatase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    919091-61-5
  • Formula Weight
    413.12
  • Molecular Formula
    C19H13Cl4NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Clc1ccc(\C=C2/CNC\C(=C/c3ccc(Cl)c(Cl)c3)C2=O)cc1Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Jin, Yongsheng, et al. 3,5-diaryl-ylidene piperidone derivatives and application thereof in preparing blood glucose-reducing and fat-reducing medicine. CN103626692A.
molnova catalog
related products
  • CDC25B-IN-1

    CDC25B-IN-1 is an inhibitor of CDC25B with a Ki of 8.5 μM.

  • Rbin-2

    Rbin-2 is a cell-permeable, potent, selective and reversible inhibitor of Midasin (Mdn1).

  • SHP099

    SHP099 free base is an effective, selective, orally bioavailable, and efficacious SHP2 inhibitor (IC50 =0.07 μM and p-ERK modulation in cells IC50 = 0.250 μM). SHP099 shows dose-dependent pathway inhibition and antitumor activity in xenograft models.